Key result
Higher body mass index was significantly associated with an increased prevalence of left ventricular diastolic dysfunction in women aged 40-60 years with preserved ejection fraction (p<0.0001).
Why the study?
Subclinical left ventricular diastolic dysfunction predicts heart failure before symptoms appear, but its prevalence across body mass index categories in women aged 40-60 years required characterization.
Is body mass index associated with left ventricular diastolic dysfunction in women aged 40-60 years with preserved ejection fraction?
Cross-Sectional (n=656)
Is body mass index associated with left ventricular diastolic dysfunction in women aged 40-60 years with preserved ejection fraction?
p-value: p=<0.0001
Higher body mass index is associated with an increased prevalence and severity of preclinical diastolic dysfunction in middle-aged women with preserved ejection fraction.
Higher BMI was associated with greater LVDD prevalence in midlife women; leaves open whether weight reduction prevents progression to HFpEF.
Introduction. Diastolic heart failure is a variant of the universal complication of diseases and heart lesions, characterized by impaired function and myocardial remodeling. Since these processes begin before the onset of symptoms, special attention is paid to identifying subclinical diastolic LV dysfunctions, as a predictor of the formation of heart failure. The objective: was to determine and characterize the prevalence of LVDD in the population of women 40–60 years old depending on BMI. Materials and methods. We examined women aged 40–60 years without clinical signs of heart failure, with preserved LVEF, who underwent an ultrasound examination to identify preclinical LVDD. Diastolic function was divided into normal and DD. Then DD was ranked as mild, moderate, and severe. Statistical processing was performed using Statistica for Windows. Results. Abnormal diastolic function detected in 383 (58.4%) patients, with the most common stage being 1: 359 (93.7%). With stage 2 DD, 23 (6.0%) patients were detected and stage 3 DD was detected in 1 (0.3%). BMI increased in proportion to the stages of DD (p<0.001). More patients with normal diastolic function have normal weight or overweight, while patients with DD were predominantly obese (p<0.001). As BMI increased, the prevalence of normal diastolic function decreased, while the prevalence of DD increased (p<0.0001). Conclusions. An increase in BMI is associated with DD in both groups of patients with obesity, hypertension and diabetes, and in an isolated group of normotensive patients without diabetes. These results may indicate that BMI is an independent predictor of DD.
No takes yet. Share an insight, caveat, or question.
Kyrychenko et al. (2019) conducted a cross-sectional in Preclinical left ventricular diastolic dysfunction (n=656). Body mass index vs. Normal weight was evaluated on Prevalence and severity of left ventricular diastolic dysfunction (p=<0.0001). Higher body mass index was significantly associated with an increased prevalence of left ventricular diastolic dysfunction in women aged 40-60 years with preserved ejection fraction (p<0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: